secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001213900-25-069658
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical reports Q2 clinical progress, cash $5.3M; CPT codes for Esteem device effective July 1
--------------------------------------------------------------------------------

- All 10 Acclaim cochlear implant trial participants activated; no serious adverse events at one-month follow-up.
- Five CPT codes for totally implantable active middle ear implants (Esteem) approved by AMA, effective July 1, 2025.
- R&D expenses decreased to $2.485M from $2.6M; G&A increased $0.5M due to severance accrual.
- Cash balance $5.3M as of June 30, 2025; net revenues increased by $10K YoY.
- Subsequent to quarter end, two US and three Australian patents issued to strengthen IP portfolio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025069658/0001213900-25-069658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025069658/ea0250901-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-069658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer